Bioequivalence for Parenteral Products [Regulatives / Guidelines]

posted by arailkar – 2020-05-29 19:21 (1214 d 16:28 ago) – Posting: # 21491
Views: 1,365

Dear Helmut,

I am interested in finding out if bioequivalence study is needed in the US when an IV formulation is changed to a subcutaneous formulation. I would also appreciate if you can please give me references to US FDA Guidance document that addresses this topic. Thank you very much.


Complete thread:

UA Flag
 Admin contact
22,759 posts in 4,775 threads, 1,628 registered users;
13 visitors (0 registered, 13 guests [including 5 identified bots]).
Forum time: 11:49 CEST (Europe/Vienna)

Whenever a theory appears to you as the only possible one,
take this as a sign that you have neither understood the theory
nor the problem which it was intended to solve.    Karl R. Popper

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz